We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

SEBIA

Sebia provides clinical protein electrophoresis equipment and reagents for in-vitro diagnostic testing, including sys... read more Featured Products: More products

Download Mobile App




Paraproteins Identification Methods Compared for Monoclonal Gammopathies

By LabMedica International staff writers
Posted on 18 Mar 2021
Monoclonal gammopathy, also known as paraproteinemia, is the presence of excessive amounts of myeloma protein or monoclonal gamma globulin in the blood. More...
It is usually due to an underlying immunoproliferative disorder or hematologic neoplasms, especially multiple myeloma.

In monoclonal gammopathies, the full laboratory workup for initial diagnosis and disease relapse includes a complete blood count and differential, a peripheral blood smear, a chemistry screen including calcium and creatinine, serum protein electrophoresis, serum immunofixation (IFE), immunoturbidimetric or immunonephelometric quantification of serum Ig, routine urinalysis, 24-hour urine collection for electrophoresis and immunofixation, serum β2-microglobulin, lactate dehydrogenase, and measurement of serum free light chains.

Medical Laboratory Scientists at the MDI Limbach Berlin GmbH (Berlin, Germany) evaluated methodic differences between serum immunofixation and serum immunosubtraction as well as in the quantitation of serum immunoglobulins on different clinical chemical platforms. The scientists used 322 unique routine patient samples and used for comparison between serum immunofixation (IFE) on HYDRASIS 2 (Sebia, Lisses, France) and serum immunosubtraction (ISE) on Sebia's CAPILLARYS 2 as well as between quantitation results of immunoglobulin A, G, and M on the ARCHITECT c16000PLUS (Abbott Core Laboratory, Abbott Park, IL, USA) and the Cobas c 502 module (Roche Diagnostics, Rotkreuz, Switzerland). The median age of patients was 75 years.

The scientists reported that IFE detected and identified a total of 69 paraproteinemias, while ISE only detected monoclonal proteins in 51 samples, a difference of 26%. ISE failed to detect 6/7 samples with biclonal paraproteinemias as well as 8/11 monoclonal paraproteins involving IgA and 4/10 monoclonal paraproteins involving IgM identified by IFE. For monoclonal paraproteins involving IgG, the total number of detections was 39 in IFE and 38 in ISE. Samples with paraproteinemia were nearly evenly split between sexes. Paraprotein identification differed remarkably between immunofixation and immunosubtraction. Quantitation of serum immunoglobulins showed higher values on Abbott's ARCHITECT c16000PLUS when compared with Roche's Cobas c 502 module.

The authors concluded that identification of paraproteins via serum immunosubtraction is inferior to serum immunofixation, which can have implications on the diagnosis and monitoring of patients with monoclonal gammopathy. If immunoturbidimetric quantitation of immunoglobulins is used for follow-up, the same clinical-chemical platform should be used consistently. The study was published on February 26, 2021 in the journal Archives of Pathology and Laboratory Medicine.

Related Links:
MDI Limbach Berlin GmbH
Sebia
Abbott Core Laboratory
Roche Diagnostics



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PlGF Test
Quidel Triage PlGF Test
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.